查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866664

脱钙同种异体移植：全球市场份额和排名、总收入和需求预测（2025-2031年）

Demineralized Allografts - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 97 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球海水淡化同种异体移植市场规模估计为 5.83 亿美元，预计到 2031 年将成长至 6.72 亿美元，2025 年至 2031 年的复合年增长率为 2.0%。

本报告对近期与脱矿异体移植相关的关税调整和国际战略反制措施进行了全面评估，包括其对跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响。

脱钙同种异体移植片是指从同一物种的个体身上获取组织，然后移植到该物种的另一个个体体内。尸体同种异体移植片已成为自体骨移植的可行替代方案。它们有结构化和颗粒状两种形式，可透过新鲜冷冻或冷冻干燥来製备。由于这些移植片为宿主组织生长提供结构框架或支架，因此具有骨传导性。然而，它们的骨诱导性充其量只能算是一般。植入后，宿主预计会出现复杂的免疫反应。冷冻或冷冻干燥同种异体移植片对于最大限度地减少这种反应至关重要；然而，这可能会改变材料的基本特性。 2024年，全球脱钙同种异体移植片的产量约2,010万片，全球平均市场价格约为每片20.9美元。

整形外科和牙科手术的结构性增长，加上人口老化和微创技术的普及，正在扩大脱钙同种异体骨移植在脊椎融合手术、创伤修復和植入相关增强手术中的应用。上市公司文件和券商报告均指出，包含固定係统、标准化临床路径和产品创新（例如，用于改善支架形成的纤维化脱钙骨基质）的捆绑式解决方案是推动价值成长的两大因素。同时，政府资助的医疗服务体系、组织库管治以及医院品管的改进，提高了原材料的供应量和临床医生的信心，从而促进了脱钙同种异体骨移植的大规模应用和国际市场准入。

供体供应的波动、监管的差异以及跨境核准的缺口造成了不确定性。不同司法管辖区对标籤和临床证据的要求各不相同，推高了註册和营运成本。采购、灭菌和低温运输物流成本的上升正在挤压小型公司的利润空间，而大型公司则透过通路、关键意见领袖 (KOL) 网路和临床证据保持定价权。更严格的合规审查和医院采购倡议提高了价格透明度，迫使製造商加强对产品一致性、临床数据和端到端可追溯性的投资。

临床医生优先考虑「即用型、可塑形和可预测性」的产品，并倾向于将骨膜移植片（脱钙骨基质，DBM）与载体、合成材料和屏障膜相结合的一体化包装。纤维状、可压缩型产品以及自体/合成混合型产品在脊椎和牙科领域市场份额不断增长。数位化工作流程和共识指南正在推动循证决策，而医院则优先考虑多中心追踪研究和真实世界临床数据。感染控制和合规性可追溯性（无菌保证、条码追踪、温度记录）正成为关键的采购标准，而生物活性和加工一致性在高端市场也越来越受到青睐。

本报告旨在对全球脱矿同种异体移植市场按地区/国家、类型和应用进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

脱钙同种异体移植市场规模、估算和预测以单位（千）和收入（百万美元）为单位呈现，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定脱钙同种异体移植的业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Medtronic
  • J &J（DePuy Synthes）
  • Zimmer
  • Stryker Corporation
  • Straumann
  • RTI Surgical
  • Wright Medical Group
  • SeaSpine
  • Xtant Medical
  • Hans Biomed

按类型分類的细分市场

  • 凝胶
  • 油灰
  • 带碎屑的腻子
  • 其他的

应用领域

  • 牙科
  • 脊椎手术
  • 创伤外科

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Demineralized Allografts was estimated to be worth US$ 583 million in 2024 and is forecast to a readjusted size of US$ 672 million by 2031 with a CAGR of 2.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Demineralized Allografts cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Demineralized Allografts is tissue harvested from one individual and implanted into another of the same species. In a search for an adequate substitute for autogenous bone, cadaveric allograft has been a viable option. Structural and morselized forms are available and prepared as either fresh-frozen or freeze-dried. These grafts provide a structural framework or scaffold for host tissue to grow, hence making allograft osteoconductive. Conversely, its osteoinductive properties are mediocre at best. Upon implantation, the host is expected to experience an intricate immune response. Freezing or freeze-drying the allograft is crucial in minimizing this reaction; however, the fundamental properties of the material may be altered. In 2024, global Demineralized Allografts production reached approximately 20.1 m units, with an average global market price of around US$ 20.9 perunit

Structural growth in orthopedic and dental procedures-amplified by aging demographics and minimally invasive techniques-is expanding penetration of demineralized allografts across spinal fusion, trauma repair, and implant-related augmentation. Public company reports and broker coverage highlight bundled solutions with fixation systems, standardized clinical pathways, and product innovation (e.g., fiberized DBM for better scaffolding) as dual engines of value. Concurrently, government improvements in donation systems, tissue bank governance, and hospital quality controls enhance raw material availability and clinician confidence, underpinning scalable adoption and international market access.

Volatility in donor supply, heterogeneous regulations, and cross-border approval gaps introduce uncertainty-different jurisdictions impose varying requirements on labeling and clinical evidence, elevating registration and operating costs. Rising expenses in sourcing, sterilization, and cold-chain logistics pressure margins for smaller players, while leaders retain pricing power through channels, KOL networks, and clinical evidence. Tightening compliance reviews and hospital procurement initiatives increase price transparency, pushing manufacturers to invest more in product consistency, clinical data, and end-to-end traceability.

Clinicians prioritize "ready-to-use, moldable, and predictable" solutions, favoring integrated packs that combine DBM with carriers, synthetics, and barrier membranes. Fiberized, compressible formats and hybrid use with autograft/synthetics are gaining share in spine and dental indications. Digital workflows and consensus guidelines steer evidence-based selection, with hospitals valuing multicenter follow-up and real-world data. Infection control and compliance traceability-sterility assurance, barcode tracking, and temperature logs-are emerging as key purchasing criteria, while premium segments show a rising bias toward bioactivity and processing consistency.

This report aims to provide a comprehensive presentation of the global market for Demineralized Allografts, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Demineralized Allografts by region & country, by Type, and by Application.

The Demineralized Allografts market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Demineralized Allografts.

Market Segmentation

By Company

  • Medtronic
  • J &J (DePuy Synthes)
  • Zimmer
  • Stryker Corporation
  • Straumann
  • RTI Surgical
  • Wright Medical Group
  • SeaSpine
  • Xtant Medical
  • Hans Biomed

Segment by Type

  • Gel
  • Putty
  • Putty with Chips
  • Others

Segment by Application

  • Dental
  • Spine Surgery
  • Trauma Surgery

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Demineralized Allografts manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Demineralized Allografts in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Demineralized Allografts in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Demineralized Allografts Product Introduction
  • 1.2 Global Demineralized Allografts Market Size Forecast
    • 1.2.1 Global Demineralized Allografts Sales Value (2020-2031)
    • 1.2.2 Global Demineralized Allografts Sales Volume (2020-2031)
    • 1.2.3 Global Demineralized Allografts Sales Price (2020-2031)
  • 1.3 Demineralized Allografts Market Trends & Drivers
    • 1.3.1 Demineralized Allografts Industry Trends
    • 1.3.2 Demineralized Allografts Market Drivers & Opportunity
    • 1.3.3 Demineralized Allografts Market Challenges
    • 1.3.4 Demineralized Allografts Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Demineralized Allografts Players Revenue Ranking (2024)
  • 2.2 Global Demineralized Allografts Revenue by Company (2020-2025)
  • 2.3 Global Demineralized Allografts Players Sales Volume Ranking (2024)
  • 2.4 Global Demineralized Allografts Sales Volume by Company Players (2020-2025)
  • 2.5 Global Demineralized Allografts Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Demineralized Allografts Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Demineralized Allografts Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Demineralized Allografts
  • 2.9 Demineralized Allografts Market Competitive Analysis
    • 2.9.1 Demineralized Allografts Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Demineralized Allografts Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Demineralized Allografts as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Gel
    • 3.1.2 Putty
    • 3.1.3 Putty with Chips
    • 3.1.4 Others
  • 3.2 Global Demineralized Allografts Sales Value by Type
    • 3.2.1 Global Demineralized Allografts Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Demineralized Allografts Sales Value, by Type (2020-2031)
    • 3.2.3 Global Demineralized Allografts Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Demineralized Allografts Sales Volume by Type
    • 3.3.1 Global Demineralized Allografts Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Demineralized Allografts Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Demineralized Allografts Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Demineralized Allografts Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Dental
    • 4.1.2 Spine Surgery
    • 4.1.3 Trauma Surgery
  • 4.2 Global Demineralized Allografts Sales Value by Application
    • 4.2.1 Global Demineralized Allografts Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Demineralized Allografts Sales Value, by Application (2020-2031)
    • 4.2.3 Global Demineralized Allografts Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Demineralized Allografts Sales Volume by Application
    • 4.3.1 Global Demineralized Allografts Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Demineralized Allografts Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Demineralized Allografts Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Demineralized Allografts Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Demineralized Allografts Sales Value by Region
    • 5.1.1 Global Demineralized Allografts Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Demineralized Allografts Sales Value by Region (2020-2025)
    • 5.1.3 Global Demineralized Allografts Sales Value by Region (2026-2031)
    • 5.1.4 Global Demineralized Allografts Sales Value by Region (%), (2020-2031)
  • 5.2 Global Demineralized Allografts Sales Volume by Region
    • 5.2.1 Global Demineralized Allografts Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Demineralized Allografts Sales Volume by Region (2020-2025)
    • 5.2.3 Global Demineralized Allografts Sales Volume by Region (2026-2031)
    • 5.2.4 Global Demineralized Allografts Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Demineralized Allografts Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Demineralized Allografts Sales Value, 2020-2031
    • 5.4.2 North America Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Demineralized Allografts Sales Value, 2020-2031
    • 5.5.2 Europe Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Demineralized Allografts Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Demineralized Allografts Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Demineralized Allografts Sales Value, 2020-2031
    • 5.7.2 South America Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Demineralized Allografts Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Demineralized Allografts Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Demineralized Allografts Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Demineralized Allografts Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Demineralized Allografts Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Demineralized Allografts Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Demineralized Allografts Sales Value, 2020-2031
    • 6.3.2 United States Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Demineralized Allografts Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Demineralized Allografts Sales Value, 2020-2031
    • 6.4.2 Europe Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Demineralized Allografts Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Demineralized Allografts Sales Value, 2020-2031
    • 6.5.2 China Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Demineralized Allografts Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Demineralized Allografts Sales Value, 2020-2031
    • 6.6.2 Japan Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Demineralized Allografts Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Demineralized Allografts Sales Value, 2020-2031
    • 6.7.2 South Korea Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Demineralized Allografts Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Demineralized Allografts Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Demineralized Allografts Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Demineralized Allografts Sales Value, 2020-2031
    • 6.9.2 India Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Demineralized Allografts Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Medtronic
    • 7.1.1 Medtronic Company Information
    • 7.1.2 Medtronic Introduction and Business Overview
    • 7.1.3 Medtronic Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Medtronic Demineralized Allografts Product Offerings
    • 7.1.5 Medtronic Recent Development
  • 7.2 J &J (DePuy Synthes)
    • 7.2.1 J &J (DePuy Synthes) Company Information
    • 7.2.2 J &J (DePuy Synthes) Introduction and Business Overview
    • 7.2.3 J &J (DePuy Synthes) Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 J &J (DePuy Synthes) Demineralized Allografts Product Offerings
    • 7.2.5 J &J (DePuy Synthes) Recent Development
  • 7.3 Zimmer
    • 7.3.1 Zimmer Company Information
    • 7.3.2 Zimmer Introduction and Business Overview
    • 7.3.3 Zimmer Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Zimmer Demineralized Allografts Product Offerings
    • 7.3.5 Zimmer Recent Development
  • 7.4 Stryker Corporation
    • 7.4.1 Stryker Corporation Company Information
    • 7.4.2 Stryker Corporation Introduction and Business Overview
    • 7.4.3 Stryker Corporation Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Stryker Corporation Demineralized Allografts Product Offerings
    • 7.4.5 Stryker Corporation Recent Development
  • 7.5 Straumann
    • 7.5.1 Straumann Company Information
    • 7.5.2 Straumann Introduction and Business Overview
    • 7.5.3 Straumann Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Straumann Demineralized Allografts Product Offerings
    • 7.5.5 Straumann Recent Development
  • 7.6 RTI Surgical
    • 7.6.1 RTI Surgical Company Information
    • 7.6.2 RTI Surgical Introduction and Business Overview
    • 7.6.3 RTI Surgical Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 RTI Surgical Demineralized Allografts Product Offerings
    • 7.6.5 RTI Surgical Recent Development
  • 7.7 Wright Medical Group
    • 7.7.1 Wright Medical Group Company Information
    • 7.7.2 Wright Medical Group Introduction and Business Overview
    • 7.7.3 Wright Medical Group Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Wright Medical Group Demineralized Allografts Product Offerings
    • 7.7.5 Wright Medical Group Recent Development
  • 7.8 SeaSpine
    • 7.8.1 SeaSpine Company Information
    • 7.8.2 SeaSpine Introduction and Business Overview
    • 7.8.3 SeaSpine Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 SeaSpine Demineralized Allografts Product Offerings
    • 7.8.5 SeaSpine Recent Development
  • 7.9 Xtant Medical
    • 7.9.1 Xtant Medical Company Information
    • 7.9.2 Xtant Medical Introduction and Business Overview
    • 7.9.3 Xtant Medical Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Xtant Medical Demineralized Allografts Product Offerings
    • 7.9.5 Xtant Medical Recent Development
  • 7.10 Hans Biomed
    • 7.10.1 Hans Biomed Company Information
    • 7.10.2 Hans Biomed Introduction and Business Overview
    • 7.10.3 Hans Biomed Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Hans Biomed Demineralized Allografts Product Offerings
    • 7.10.5 Hans Biomed Recent Development

8 Industry Chain Analysis

  • 8.1 Demineralized Allografts Industrial Chain
  • 8.2 Demineralized Allografts Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Demineralized Allografts Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Demineralized Allografts Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Demineralized Allografts Market Trends
  • Table 2. Demineralized Allografts Market Drivers & Opportunity
  • Table 3. Demineralized Allografts Market Challenges
  • Table 4. Demineralized Allografts Market Restraints
  • Table 5. Global Demineralized Allografts Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Demineralized Allografts Revenue Market Share by Company (2020-2025)
  • Table 7. Global Demineralized Allografts Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Demineralized Allografts Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Demineralized Allografts Price by Company (2020-2025) & (USD/Unit)
  • Table 10. Key Manufacturers Demineralized Allografts Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Demineralized Allografts Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Demineralized Allografts
  • Table 13. Global Demineralized Allografts Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Demineralized Allografts as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Demineralized Allografts Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Demineralized Allografts Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Demineralized Allografts Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Demineralized Allografts Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Demineralized Allografts Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Demineralized Allografts Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Demineralized Allografts Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Demineralized Allografts Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Demineralized Allografts Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Demineralized Allografts Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Demineralized Allografts Price by Type (2020-2025) & (USD/Unit)
  • Table 27. Global Demineralized Allografts Price by Type (2026-2031) & (USD/Unit)
  • Table 28. Global Demineralized Allografts Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Demineralized Allografts Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Demineralized Allografts Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Demineralized Allografts Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Demineralized Allografts Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Demineralized Allografts Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Demineralized Allografts Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Demineralized Allografts Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Demineralized Allografts Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Demineralized Allografts Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Demineralized Allografts Price by Application (2020-2025) & (USD/Unit)
  • Table 39. Global Demineralized Allografts Price by Application (2026-2031) & (USD/Unit)
  • Table 40. Global Demineralized Allografts Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Demineralized Allografts Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Demineralized Allografts Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Demineralized Allografts Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Demineralized Allografts Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Demineralized Allografts Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Demineralized Allografts Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Demineralized Allografts Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Demineralized Allografts Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Demineralized Allografts Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Demineralized Allografts Average Price by Region (2020-2025) & (USD/Unit)
  • Table 51. Global Demineralized Allografts Average Price by Region (2026-2031) & (USD/Unit)
  • Table 52. Key Countries/Regions Demineralized Allografts Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Demineralized Allografts Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Demineralized Allografts Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Demineralized Allografts Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Demineralized Allografts Sales Volume, (2026-2031) & (K Units)
  • Table 57. Medtronic Company Information
  • Table 58. Medtronic Introduction and Business Overview
  • Table 59. Medtronic Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 60. Medtronic Demineralized Allografts Product Offerings
  • Table 61. Medtronic Recent Development
  • Table 62. J &J (DePuy Synthes) Company Information
  • Table 63. J &J (DePuy Synthes) Introduction and Business Overview
  • Table 64. J &J (DePuy Synthes) Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 65. J &J (DePuy Synthes) Demineralized Allografts Product Offerings
  • Table 66. J &J (DePuy Synthes) Recent Development
  • Table 67. Zimmer Company Information
  • Table 68. Zimmer Introduction and Business Overview
  • Table 69. Zimmer Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 70. Zimmer Demineralized Allografts Product Offerings
  • Table 71. Zimmer Recent Development
  • Table 72. Stryker Corporation Company Information
  • Table 73. Stryker Corporation Introduction and Business Overview
  • Table 74. Stryker Corporation Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 75. Stryker Corporation Demineralized Allografts Product Offerings
  • Table 76. Stryker Corporation Recent Development
  • Table 77. Straumann Company Information
  • Table 78. Straumann Introduction and Business Overview
  • Table 79. Straumann Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 80. Straumann Demineralized Allografts Product Offerings
  • Table 81. Straumann Recent Development
  • Table 82. RTI Surgical Company Information
  • Table 83. RTI Surgical Introduction and Business Overview
  • Table 84. RTI Surgical Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 85. RTI Surgical Demineralized Allografts Product Offerings
  • Table 86. RTI Surgical Recent Development
  • Table 87. Wright Medical Group Company Information
  • Table 88. Wright Medical Group Introduction and Business Overview
  • Table 89. Wright Medical Group Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 90. Wright Medical Group Demineralized Allografts Product Offerings
  • Table 91. Wright Medical Group Recent Development
  • Table 92. SeaSpine Company Information
  • Table 93. SeaSpine Introduction and Business Overview
  • Table 94. SeaSpine Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 95. SeaSpine Demineralized Allografts Product Offerings
  • Table 96. SeaSpine Recent Development
  • Table 97. Xtant Medical Company Information
  • Table 98. Xtant Medical Introduction and Business Overview
  • Table 99. Xtant Medical Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 100. Xtant Medical Demineralized Allografts Product Offerings
  • Table 101. Xtant Medical Recent Development
  • Table 102. Hans Biomed Company Information
  • Table 103. Hans Biomed Introduction and Business Overview
  • Table 104. Hans Biomed Demineralized Allografts Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 105. Hans Biomed Demineralized Allografts Product Offerings
  • Table 106. Hans Biomed Recent Development
  • Table 107. Key Raw Materials Lists
  • Table 108. Raw Materials Key Suppliers Lists
  • Table 109. Demineralized Allografts Downstream Customers
  • Table 110. Demineralized Allografts Distributors List
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Demineralized Allografts Product Picture
  • Figure 2. Global Demineralized Allografts Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Demineralized Allografts Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Demineralized Allografts Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Demineralized Allografts Sales Price (2020-2031) & (USD/Unit)
  • Figure 6. Demineralized Allografts Report Years Considered
  • Figure 7. Global Demineralized Allografts Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Demineralized Allografts Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Demineralized Allografts Revenue in 2024
  • Figure 10. Demineralized Allografts Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Gel Picture
  • Figure 12. Putty Picture
  • Figure 13. Putty with Chips Picture
  • Figure 14. Others Picture
  • Figure 15. Global Demineralized Allografts Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Demineralized Allografts Sales Value Market Share by Type, 2024 & 2031
  • Figure 17. Global Demineralized Allografts Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 18. Global Demineralized Allografts Sales Volume Market Share by Type, 2024 & 2031
  • Figure 19. Global Demineralized Allografts Price by Type (2020-2031) & (USD/Unit)
  • Figure 20. Product Picture of Dental
  • Figure 21. Product Picture of Spine Surgery
  • Figure 22. Product Picture of Trauma Surgery
  • Figure 23. Global Demineralized Allografts Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 24. Global Demineralized Allografts Sales Value Market Share by Application, 2024 & 2031
  • Figure 25. Global Demineralized Allografts Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 26. Global Demineralized Allografts Sales Volume Market Share by Application, 2024 & 2031
  • Figure 27. Global Demineralized Allografts Price by Application (2020-2031) & (USD/Unit)
  • Figure 28. North America Demineralized Allografts Sales Value (2020-2031) & (US$ Million)
  • Figure 29. North America Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Europe Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Asia Pacific Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Asia Pacific Demineralized Allografts Sales Value by Region (%), 2024 VS 2031
  • Figure 34. South America Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. South America Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Middle East & Africa Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Middle East & Africa Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Key Countries/Regions Demineralized Allografts Sales Value (%), (2020-2031)
  • Figure 39. Key Countries/Regions Demineralized Allografts Sales Volume (%), (2020-2031)
  • Figure 40. United States Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. United States Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • Figure 42. United States Demineralized Allografts Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Europe Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Europe Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Europe Demineralized Allografts Sales Value by Application (%), 2024 VS 2031
  • Figure 46. China Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. China Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • Figure 48. China Demineralized Allografts Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Japan Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. Japan Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • Figure 51. Japan Demineralized Allografts Sales Value by Application (%), 2024 VS 2031
  • Figure 52. South Korea Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. South Korea Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • Figure 54. South Korea Demineralized Allografts Sales Value by Application (%), 2024 VS 2031
  • Figure 55. Southeast Asia Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. Southeast Asia Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • Figure 57. Southeast Asia Demineralized Allografts Sales Value by Application (%), 2024 VS 2031
  • Figure 58. India Demineralized Allografts Sales Value, (2020-2031) & (US$ Million)
  • Figure 59. India Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • Figure 60. India Demineralized Allografts Sales Value by Application (%), 2024 VS 2031
  • Figure 61. Demineralized Allografts Industrial Chain
  • Figure 62. Demineralized Allografts Manufacturing Cost Structure
  • Figure 63. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed